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Within recent years, there has been considerable interest in the use of anti- 
metabolic drugs in  organ  transplantation  and for  the  treatment of various 
immunologically related diseases. These drugs have been shown to have both 
immunosuppressive (1-3)  and anti-inflammatory effects (4-6),  but the actual 
mechanisms underlying these effects are not well established. 6-Mercaptopurine 
(6-MP), which has an inhibitory effect on nucleic acid synthesis (7-10),  is one 
of these agents which has been intensively studied. In 1962, Page, Condie, and 
Good  (4)  demonstrated that  6-MP  virtually eliminated the  appearance  of 
mononuclear cells at a local inflammatory site. This effect developed only aSter 
a  requisite period of administration of the drug,  the duration of which was 
inversely related to the dose. The same anti-inflammatory effect was subse- 
quently demonstrated in humans who were receiving 6-MP for the treatment of 
neoplastic disease (5). 
The mononuclear cell populations of the tuberculin hypersensitivity lesion 
(11),  the inflammatory reaction produced by local injection of fibrinogen (12) 
and of peritoneal exudates (13) have been shown to consist largely of hematog- 
enous cells thought to be derived from rapidly proliferating precursors in the 
bone marrow. In the present report, the possibility was investigated that 6-MP 
might suppress inflammation through interference with the proliferation of the 
precursors of these mononuclear cells. In these experiments, the effect of 6-MP 
on the intensity of mononuclear cell infiltration of an induced skin lesion in 
rabbits has been correlated with the numbers of the various types of mono- 
nuclear cells in the blood. The replication of these cells in vitro, as measured by 
incorporation of tritiated thymidine (sI-I-Tdr), has been determined simultane- 
ously. The results obtained have demonstrated that administration of 6-MP 
decreases predominantly the  numbers of monocytes and large,  proliferating 
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lymphocytes in the blood concurrently with the decrease of mononuclear  cells 
in inflammatory sites.  This action of 6-MP appears  to be the basis of its anti- 
inflammatory effect. 
Materials and Methods 
Anlmals.--In  all experiments,  albino  rabbits  of both  sexes,  weighing 2.0-3.0  kg,  were 
obtained from a  single local breeder in groups of eight from the same litter and randomly 
separated into two equal groups. One was treated with 6-MP and the other served as a con= 
trol group. Both groups were pair-fed a  standard  Purina pellet diet in order to keep weight 
gain or loss equal in the two groups. 
6-Mercaptopurine.--6-MP was obtained in the form of the sodium salt in 0.5 g sterile vials 
(kindly supplied by Dr. Donald S. Searle of Burroughs Wellcome & Co., Tuckahoe, N. ¥.) 
and water added to a concentration of 37.5 mg/ml. A fresh vial was used daily, and the dis- 
solved drug injected immediately after addition of water. Injections were given intravenously 
into the marginal ear vein daily for 10 days in a dosage of 18 mg/kg. Injected solutions had a 
pH of 10.5. They were only mildly irritating to the vein. Control animals received equivalent 
volumes of pI-I 10.5 phosphate-buffered saline. 
Turpentine Injeaions.--In  order to increase the blood levels of large mononuclear cells, 
turpentine was injected subcutaneously on day 8. 0.1 ml of a solution of turpentine in olive oil 
(1:5) was injected into four sites on the back. 
Inflammatory Response.--The studies of Page and coworkers (4) were repeated using four 
6-MP treated animals and four controls in each experiment. On day 9, 0.1  ml of fresh egg 
white, mixed with India ink, was injected subcutaneously into four sites along the rabbit's 
shaved back on the opposite side from the turpentine injections. Animals were anesthetized 
with  intravenous  Soumopentyl  (pentobarbital  sodium,  Pitman-Moore,  Indianapolis,  Ind.) 
and  biopsy specimens obtained 4-6 hr after injection. The loose subcutaneous  connective 
tissue was spread on clean glass slides,  the tissue fixed by air-drylng, and then stained with 
Wright-Giemsa stain as described by Page and coworkers and by Kolouch (4, 14).  Counts of 
500 cells were done on the tissue sections,  differentiating only between mononuclear and poly- 
morphonudear  cells.  Percentages of mononuclear cells  containing  carbon particles derived 
from India ink were also tabulated. 
Cell Counts.--Total white blood cell and differential counts were done on blood obtained 
from the ear in treated and control animals on days 9 and  11. In the differential counts, a 
total of 500 cells were counted per animal. Leukocytes were classified as neutrophils (including 
eosinophils), basophils, monocytes, and large, medium, and small lymphocytes. Small lympho- 
cytes were 7 #  or less  in diameter. Medium lymphocytes ranged between 7-14 #  and  large 
lymphocytes were larger than 14/z in diameter. 
Monocytes were classified  according  to  the  criteria of  Spector and  coworkers  (12) for 
"typical" monocytes. In order to better define this cell type, differential counts were carried 
out on buffy coat preparations simultaneously with measurements of phagocytosis of carbon 
particles in vitro. To 40 ml of heparinized blood, 10 ml of 1% dextran and 12 drops of a  1:50 
dilution of carbon black (Gunther Wagner-Pelikan, Hanover, Germany, No. Cl1143a) were 
added, and the blood was allowed to stand for 1 hr at 37°C.  The sedimented erythrocytes 
were then separated, and three drops of the supernatant were placed in the well of a Shandon 
cytocentrifuge (SCA-0001)  and spun at 400 rpm. Smears, made from these preparations,  were 
then stained with Wright's stain and differential counts performed on 500  cells.  Percentages 
of the mononuclear cells which contained carbon were tabulated.  In four untreated and  four 
treated animals examined on  day  13,  mean values of  86%  and  65%,  respectively, of  the ERIC R.  lrtJ'RD AND MORRIS ZIFI?  787 
cells with the appearance of monocytes had phagocytosed carbon particles, while this was rare 
in the ease of the other mononuclear cells. 
8H-Tdr Incorporation.--The  method of Vischer and Stastny (15) was used. Supernatant 
plasma, obtained as above, following  dextran sedimentation was centrifuged at 2000 rpm and 
the cell pellet was resuspended in Hanks' minimum essential medium (Grand Island Bio- 
logical Co., Grand Island, N.Y.) with added glutamine, penicillin, streptomycin, and Mycosta- 
tin. Cell counts were adjusted to a concentration of 107 celis/ml. 1 ml was placed in each of four 
plastic flasks and to each flask was added 3.25 ml of the medium, 0.75 cc of plasma from the 
same animal, and 0.1 ml 3H-Tdr containing 0.1 gc (specific  activity, 0.67 c/m~, New England 
Nuclear Corp., Boston, Mass.). In one flask, the aH-Tdr was added after the culture period, 
and this served as a zero time control. The other three flasks were treated  identically. After 
incubation  for I hr in a 37  ° incubator, the contents were transferred to test tubes, centrifuged, 
and washed five times with phosphate-buffered saline, pH 7.2. Two of these washings contained 
an excess of cold thymidine as described by Holm and Perlmann (16). The cells were then 
dissolved in I ml of 0.1 N NaOH, transferred tobottles  containing  Bray's  phosphor, and counted 
in a  Beckman 200 liquid scintillation counter with thixotropic gel  (CAB-O-SIL, Packard 
Instrument Co., Downers Grove, Ill.) Counts were corrected for quenching and efficiency,  and 
results expressed as disintegrations per minute (dpm). 
Radioautography.--lO 7 cells were obtained and pulse labeled for 1 hr in vitro as described 
above, then removed from the flask, centrifuged, suspended in fetal calf serum, and centrifuged 
again. The moist pellet was brushed on clean glass slides which were then dipped in Kodak 
NTB-3 nuclear track emulsion, stored 1 wk in the cold, and developed. Slides  were then stained 
with Leishman's stain  and differentialcellcounts made. A minimum  of 5 grains per nucleus was 
required to record a cell as labeled. 
Statistical Methods.--A student's t test for comparison of two independent samples was 
used to compare data from treated and control animals with the assumption that the alternate 
hypothesis was one sided. For the correlation of numbers of blood mononuclear cells with 
tissue monounclear cells expressed as per cent of total cells, a computer program was used to 
compute means, standard deviations and Pearson correlation coefficients.  An IBM 1800 digital 
computer was used for all calculations. 
RESULTS 
Effect  on  Circulating  Leukocytes.--On  the 9th day of 6-MP administration 
and following injection of turpentine subcutaneously on day 8, no difference in 
total blood  leukocyte  counts was  observed in treated  and  control  animals 
(Table I). Total numbers of neutrophils, total mononuclear cells, and medium 
and small lymphocytes (Tables I  and II) were all similar in both groups at this 
time. There were, however, significant decreases in the large lymphocytes and 
monocytes in the treated animals relative to the controls. 
Following subcutaneous injection of egg white and India ink on the 9th day 
and excision of  the  injection site  shortly thereafter,  the  above counts were 
repeated on day 11. On this day, the reductions in the numbers of monocytes 
and large lymphocytes in the treated animals had become marked and highly 
significant. Moderate, but statistically significant decreases in counts of total 
leukocytes, neutrophils, total mononuclear ceils (Table I), and medium-sized 
lymphocytes (Table II)  were  now observed in the  treated  animals as  corn- 788  ANTI-IN~LAMWrATORY ACTION OF  6-MERCAPTOPURINE 
pared with the controls. On the other hand, again no difference was seen in the 
small lymphocyte counts. 
It may be noted (Table II) that the marked differences in the monocyte and 
large lymphocyte counts of the  treated and control animals seen on day  11 
reflect, to a  considerable extent, increases in the numbers of these cell types 
which occurred in the control group between the 9th and llth days. These in- 
creases were, presumably, a result of the inflammatory stimulus produced by 
the turpentine and egg white injections and the biopsy procedure. The differ- 
TABLE I 
Blood Leukocyte Counts in 6-MP-Treated and Control Animals 
Day  Group  Total leukocytes  Neutrophils  Total  mononuclear  cells 
9  Controls  (12) 
11 
6-MP  (12) 
Controls (10) 
6-MP  (I0) 
10,108 
(4100-18,300) 
9191 
(4750-15,000) 
(~.S.)* 
16,375 
(6750-28,250) 
9670 
(3700-17,750) 
(e < o.oz5) 
4052 
(1435-8630) 
3852 
(1790-6750) 
(~.s.) 
5408 
(2216-9100) 
3232 
(889-6830) 
(P < 0.025) 
6055 
(2655-9670) 
5339 
(2718-10,200) 
(.V.8.) 
10,967 
(4534-19,150) 
6438 
(2811-12,140) 
(P < O.OZ5) 
* N.S., not significant. 
ences noted,  therefore, appear to reflect an inhibitory effect of 6-MP on in- 
creases in large lymphocytes and monocytes which occurred in the controls as 
a  result of the inflammatory stimuli. 
Effect of 6-MP on Tissue Lesion.--When a mixture of egg white and India 
ink  were injected subcutaneously after 8  days of 6-MP  administration  and 
biopsy specimens of subcutaneous tissue taken 4--6 hr later using the technique 
of Kolouch (14), the results of Page and coworkers (4) were confirmed, i.e., a 
significant decrease in the mononuclear cell infiltrate in the areas of induced 
inflammation was noted. Per cent of mononuclear cells in the tissue lesions fell 
from 32 %  in the controls to 9.6%  in  the 6-MP-treated animals  (Table III, 
Figs.  1  and  2).  Although,  as  noted  above,  both  the  large  lymphocyte and 
monocyte counts in the blood were significantly depressed in the 6-MP-treated 
group at this time, a significant correlation was found (Table IV) only between ERIC R. nugD  AND  MORRIS ZIFF  789 
blood  monocyte counts and percent tissue  mononuclear  cells in the 6-MP- 
treated animals. This correlation was highly significant. There was no correla- 
tion with any other blood mononuclear cell type. 
TABLE H 
Blood Mononudear Cell Counts in 6-MP~Tre,  ated and  Cout~d Animals 
Day 
11 
Group 
Controls  (12) 
6-1VI~  (12) 
Controls  (10) 
6-MP  (I0) 
Small 
lymDhov/tes 
1158 
(  107-2949  ) 
1225 
(196-3786) 
(N.S.) 
1136 
(268-3160) 
1314 
(443--2550) 
(~.s.) 
Medium 
lymphocytes 
4056 
(1078-7580) 
3668 
(377-8840) 
(N.s.) 
7975 
(3454-12,920) 
4665 
(673-10,260) 
(P <  0.05) 
Large 
lymphocytes 
444 
(211-770) 
185 
(14-460) 
(e <  o.ooz) 
1038 
(216-2145) 
230 
(36-612) 
(e <  o.ool) 
Monocytes 
268 
(56-55O) 
99 
(0-418) 
(P < O,Og5) 
522 
(108-1300) 
9O 
(0--195) 
(P <  0.005) 
TABLE HI 
Simultaneous Cell Counts ~  Blood and Tissue Lesion on Day 9 
Group 
Control (12) 
5-MP  (12) 
Total 
mononudear 
cells in blood 
5055 
5339 
(~.s.) 
Large lymphocytse 
in blood 
444 
185 
(1, <  o.ooz) 
Monocytes in blood 
268 
99 
(2" < 0.025) 
Mononuclear cells 
in tissue lesion 
% 
32.1 
(3.2-51.o) 
9.6 
(0.8-45.8) 
(P < O.OOZ) 
The morphology of the mononuclear cells in the inflammatory skin lesion, 
using the Kolouch technique, was not adequate for accurate differential counts 
of the mononuclear cells in most cases. However, typical blood monocytes and 
lymphocytes of varying sizes were seen. Phagocytosed carbon particles were 
observed in mononuclear cells in  all  of 24  preparations.  The percentage of 
mononuclear cells labeled with carbon varied between  25 %  and 75 %  in the 790  ANTI-INFLAM~[ATORY  ACTION  OF 6-MERCAPTOPURIN'E 
treated animals (mean, 50%) and 10 % and 97 % in the controls (mean, 54 %). 
There appeared to be no difference between the two groups in this respect. Thus, 
a large fraction of the mononuclear cells present in the inflammatory lesion in 
both groups showed phagocytic activity. 
TABLE IV 
Correlation beV,  veen Number of Mononuclear Cells in the Blood and Per Cent Mononudear  Cells 
in Tissue Lesions in 6-MP-Treated  Animals 
Correlation with per cent  tissue mononudear  Cell type  in blood  cells (correlation matrix) 
Small lymphocyte 
Medium lymphocyte 
Large lymphocyte 
Monocyte 
-0.218 
(N.S.) 
0.064 
(N.S.) 
0.121 
(N.S.) 
0.750 
(t" < o.oos) 
TABLE V 
Tritia2ed Thymidine Incorporation of Blood Mononudear  Calls in Treated and Control Animals 
(dpm SHTdr/107 Mononudear  Cells) 
Controls 
6-MP-treated 
Per cent of control 
mononuclcar cells, dpm per 10  7 
Day 9* 
12,052 
(6880-18,000) 
4725 
(3120-8580) 
39.2 
(t" <  O.OeS) 
Day  11~ 
7822 
(3290-12,580) 
4593 
(1245-7750) 
58.5 
(P <  O.OS) 
• 12 animals in each group. 
510 animals in each group. 
lncorporatlon of ~H-Tdr by Mononuclear Cells of the Blood.--The  radioactive 
counts  (dpm)  incorporated  by  the  blood  mononuclear  cells  of  the  6-MP- 
treated animals were 39.2 % of the control value on day 9 and 58.5 % on day 11 
(Table V). It is of interest that although there was a greater number of large 
mononuclear ceils in the blood of the control animals on the llth day (Table 
II)  than  on  the  9th  day,  the  radioactive  counts  per  107  mononuclear cells ERIC  R.  HURD  AND  MORRIS  Z]:FF  791 
actually fell, suggesting that there was a  smaller proportion of dividing ceils 
in the peripheral blood at this time. 
Radloautographic  Experiments.--The percentage  of  each  cell  type  labeled 
during a  1 hr in vitro incubation of the blood mononuclear cells with 3H-Tdr 
was measured by radioautography. In the control animals,  on day 9  (Table 
VI), 45.6% of the large lymphocytes and 6.3% of the medium lymphocytes 
were labeled during the 1-hr period. There was little labeling of the other cell 
TABLE VI 
Distribution of 3HTdr Labd in 2000 Mononudear  Cells of Untrealed Animals Following 1-kr 
Incubation Period 
Cell type labeled 
Large lymphocyte 
Medium lymphocyte 
Small  lymphocyte 
Monocyte 
No. cells 
counted 
46 
290 
1758 
6 
No.  with label 
21 
12 
2 
0 
Per cent with 
label 
45.6 
6.3 
0.1 
0 
TABLE VII 
E~e¢g of 6-MP on In V~ro aHTdr-Labding  of Mononudcsr  Cd~s on Day 9 
Cell  type  labeled 
Large lymphocyte 
Medium lymphocyte 
Small lymphocyte 
Monocyte 
Total  ..................... 
:No. of cells/fOe mononuclear cells with label 
Control (5) 
10,598 
5840 
I~I 
0 
17,499 
6-MP (7) 
2135  (P<O.O~3 
1780  (P<0.025) 
0  (N.s.) 
356  (N.S.) 
4271 
types. The values on day 11 were similar to those on day 9.  Thus, the pre- 
dominant mononuclear cell type which was labeled in vitro appeared to be the 
large lymphocyte. An example of this type of cell is shown in Fig. 3. 
When the number of mononuclear cells of each type which were labeled was 
determined (Table VII), it was observed that the principal cell types contribut- 
ing to the pool of labeled cells were large and medium lymphocytes, although 
the contribution of the large lymphocytes was clearly greater. This cell type, 
which formed only 7.3 %  of the total mononuclear cells,  constituted 60.4 %  of 
the labeled cells. In the 6-MP-treated animals, there was a marked reduction 
in labeled cells,  i.e. from 17,500  per 106 mononuclear cells  in the controls to 
4270  per  106 mononuclear cells,  a  fall of  76%.  Thus,  the  radioautographic 792  ANTI-INFLA~ATORY  ACTION OF  6-MERCAPTOPURINE 
measurements confirm the scintillation counting data presented above in  the 
finding that 6-MP decreased the numbers of cells capable of in vitro replication, 
and provide the additional information that the  cell type chiefly involved in 
this in vitro change is the large lymphocyte. 
DISCUSSION 
Evidence that 6-MP may decrease the infiltration of mononuclear cells in an 
inflammatory lesion induced  in the rabbit by egg albumin was presented  by 
Page, Condie, and Good (4). A similar phenomenon has been described using a 
skin  window technique in humans receiving 6-MP and other antimetabolites 
(5). The possibility that 6-MP might bring about this effect by inhibiting the 
proliferation of the precursors of the mononuclear cells which  accumulate in 
inflammatory lesions was investigated in the present study. 
The mononuclear cells present  in  inflammatory lesions  (12, 17)  and  peritoneal 
exudates (13) are short-lived ceils which are probably derived from rapidly proliferat- 
ing precursors in the bone marrow (12, 17). Kosunen and coworkers  (11), examining 
delayed  tuberculin  reactions,  described  the  mononuclear  cells  in  these  lesions  as 
"medium-large" lymphocytes which  became histiocytes in  time.  Spector,  Waiters, 
and Willoughby (12), studying a fibrinogen-induced  inflammatory skin lesion in rats 
injected with *I-I-Tdr and carbon, observed that the percentage of tissue mononuclear 
cells which was doubly labeled was the same as the per cent of doubly labeled mono- 
cytes in the peripheral blood. They concluded from this that the predominant cell in 
the inflammatory lesion was the blood monocyte. 
Since 6-MP affects both DNA and RNA synthesis (18, 19), it would be expected 
to exert a  major influence  on the mitosis of rapidly replicating ceils. This is con- 
sistent with the fact that this drug exerts its most profound toxic effects on rapidly 
proliferating tissues,  e.g. bone marrow, skin, and intestinal epithelium (20, 21). As a 
result of its action on the bone marrow, one would expect a decrease in the blood levels 
not only of polymorphonuclear leukocytes but  also of monocytes and medium  to 
large lymphocytes, since these cell types are known to be rapidly labeled in the bone 
marrow and blood following a single injection of aH-Tdr in vivo (11, 13, 22). Latta and 
Gentry (23) have, in fact, observed marked decreases in the counts of large lympho- 
cytes and monocytes in mice treated with 6-MP, and Miller and Cole (24, 25) have 
found that the only resistant ceils in lymph nodes of rats treated for long periods of 
time with  6-MP  and  other  anti-proliferative agents were  small lymphocytes and 
plasma cells. 
In the present experiments, rabbits have been injected with 6-MP and the effects 
of this agent have been examined concurrently on the counts of the various mono- 
nuclear cell types in the blood and the per cent of monounclear cells in a skin lesion 
produced by local injection of egg albumin. Following administration of 6-MP, there 
was, as previously reported (4), a marked decrease in the number of mononuclear ceils 
in the skin lesion. This was paralleled by a fall in the large mononudear cells present 
in the blood. On a dosage of 18 mg per kg of 6-MP per day, the first discernible  effects 
were noted on day 9, at which time there were significant decreases in circulating large 
lymphocytes and monocytes. The counts of total leukocytes, neutrophlls, and total ERIC R.  HURD Al~D MORRIS ZIFF  793 
mononudear cells in the blood were essentially unchanged at this time. By day II, 
however, when the circulating large lymphocytes and monocytes had fallen to very low 
levels, smaller, but significant decreases in the counts of neutrophils, total mononudear 
cells,  and medium lymphocytes had occurred. The numbers of small  lymphocytes, 
nevertheless,  continued to remain unchanged. In fact,  although not here  reported, 
small lymphocytes became the predominant white blood cell type in the peripheral 
blood following administration of 5-MP at the same dosage level for a period of 4 wk. 
From the above observations, it would appear that the reduction in mononuclear 
cell infiltration of the skin in the 6-MP-treated animals was paralleled most closely by 
decreases in large lymphocytes and monocytes in the blood. However, when the counts 
of the various mononuclear cells in the blood of these animals were correlated with 
per cent of mononuclear cells in the skin lesion, a significant correlation was found only 
in the case of the blood monocyte. This is in agreement with the conclusion of Spector 
and coworkers (12) that the monocyte is the principal blood mononudear cell which 
participates in inflammatory skin lesions.  It suggests that the large lymphocyte does 
not penetrate inflammatory skin lesions  as readily as the monocyte, at least in the 
4-6 hr period following injection of egg albumin. 
An increase  in total  blood mononudear leukocytes was observed in the  control 
animals between days 9 and 11. This resulted presumably from the stimulus produced 
by the preceding turpentine  and egg white injections and by the skin biopsy. It is 
likely also that the counts on day 9, particularly of large lymphocytes and monocytes, 
were already raised by the turpentine  injection which had been injected on day 8. 
This agent was given in order to provide an inflammatory stimulus which would effect 
the release  of adequate numbers of large mononuclear cells into the blood as found by 
Spector and coworkers using fibrinogen (12). Thus, it would appear that the lower cell 
counts observed in the 6-MP-treated  animals resulted,  in all likelihood  on day 9, 
and dearly on day 11, from an inhibition imposed by 5-MP on increases in these counts 
generated in the control animals by inflammatory stimuli. 
The polymorpbonudear leukocytes of the blood did not decrease on 6-MP until 
day 11, and even at this time the fall to 59.7% of the control values, although sig- 
nificant, was much smaller than the decreases in monocytes and large lymphocytes 
which fell to 17.2% and 22.2% of control values respectively. Presumably, this lag 
reflects the time required for maturation of the neutrophil and its subsequent storage 
period in the bone marrow. It has been shown by Otteson and Hamilton (26, 27) that 
following injection of 1~C in man, labeling of the DNA of lymphocytes precedes by 
several days the labeling of the DNA of neutrophils, the latter being delayed in their 
appearance in the blood from 4 to 6 days. If, as the data suggests, the effect of 6-MP 
is on proliferating precursor cells, one would expect from the present findings that the 
more rapidly labeled  cell  populations  of the  blood, i.e.,  the  bone marrow  derived 
mononudear cells would be depleted earlier than the neutrophils. 
Evidence that proliferating cells are decreased in number in the blood of 6-MP- 
treated animals was also obtained in experiments in which in vitro-incorporation of 
~I-I-Tdr into  blood mononudear  cells  was measured  by  scintillation  counting and 
radioautography. The reduced incorporation of 8I-I-Tdr observed in the cells  of the 
6-MP-treated animals on day 9, indicated a diminution in the number of proliferating 
cells in the blood. Presumably, the greater incorporation observed in the controls on 
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cells liberated into the blood as a result of the stimulus produced by the prior injection 
of turpentine.  By day 11, the amount of in vitro labeling was smaller,  presumably, 
because  the numbers of proliferating ceils  had  already decreased  during  the 2-day 
interval following the inflammatory stimuli.  The occurrence of increased peripheral 
mononuclear cell  counts,  noted  on day  11,  is  not  inconsistent  with  a  decrease in 
proliferating cells, since short-lived mononuclear cells may not continue to manifest 
the capacity for in vitro cell division 48 hr after the inflammatory stimulus responsible 
for their release. 
Radioautography on day 9  showed  that  the  large lymphocyte had  the  highest 
percentage of labeling when cultured in vitro with 8H-Tdr. A relatively smaller per- 
centage of medium lymphocytes and a negligible proportion of small lymphocytes and 
monocytes were labeled. When the total numbers of cells of each cell type with label 
were determined, the large and medium lymphocytes were the most numerous labeled 
ceils.  In the 6-MP-treated  animals,  the  numbers of these  cells  bearing label were 
significantly reduced. 
The preceding discussion has dealt primarily with an inflammatory lesion caused by 
egg album/n, but it is reasonable to expect that the same considerations would apply 
to the delayed hypersensitivity reaction. Lubaroff and Waksman (17) injected bone 
marrow cells into irradiated animals and subsequently induced a delayed tuberculin 
hypersensitivity lesion.  The majority of mononuclear cells in this lesion were of bone 
marrow origin. From this observation, one would expect that immunologically induced 
mononudear cell infiltration would also be diminished by 6-MP. Borel and Schwartz 
(6)  have, in fact,  demonstrated  that this drug suppresses  delayed hypersensitivity 
without inhibiting humoral antibody production. 
As indicated above, the majority of mononudear cells which accumulate in inflam- 
matory lesions are large mononuclear cells, i.e., monocytes (12) and large lymphocytes 
(11). In the present experiments, a high correlation was observed between the levels of 
monocytes in the blood and the per cent mononuclear cells in the tissue lesion induced 
by egg albumin. Furthermore, a mean of 52 % of the tissue mononuclear cells, and in 
some lesions  as high as 97%, phagocytosed carbon. These observations suggest that 
the major mononuclear cell  type in the tissue lesion is the monocyte, although the 
possibility that the large lymphocyte also accumulates in the tissue is not ruled out 
by  the present  results.  Since  6-MP appears  to reduce inflammation  by inhibiting 
proliferation of precursor ceils of the large mononuclear cells of the blood, its action on 
precursors of the monocyte would, presumably, be its most important effect in the 
present experiments. However, available evidence (11) indicates that, in the case of 
the tuberculin reaction, the large lymphocyte also makes an important contribution. 
The effects of inhibition  of proliferation of precursors of these cell  types would,  of 
course, become most apparent in the presence of an active inflammatory reaction, 
since proliferation of precursors in sites such as the bone marrow would be most active 
at this time. 
Current concepts of the mechanism of action of anti-metabolic drugs in the treat- 
ment of immunologically related diseases and in the preservation of renal homografts 
generally accept their action as being primarily immunosuppressive (1-3). However, 
it is not certain to what extent the beneficial  effects obtained result from suppression 
of the immune response and to what degree they might result from an anti-inflamma- 
tory effect.  Swanson and  Schwartz  (1)  found that clinical  improvement in patients ERIC  R.  HURD  AND  MORRIS  ZI~]~  795 
with "immunological" disease was not paralleled by suppression  of antibody forma- 
tion when such patients were immunized with hemocyanin and treated with azathi- 
oprine. This observation raised the possibility that the clinical  improvement observed 
in  these patients resulted from an anti-inflammatory effect.  The manifestation  by 
thiopurines of a  predominantly anti-inflammatory effect  appears likely  in patients 
with immunologicaUy mediated disease  who are benefited  by these drugs,  since the 
immune response  is presumably already weU established  in these patients and  since 
available evidence  (25, 28, 29)  indicates that 6-MP does not  exert a  significant  im- 
munosuppressive effect on an established immune response. 
The immunosuppressive action of 6-MP is greatest at the time of induction of the 
primary antibody response (2, 3, 25, 28, 29, 32, 33). While the macrophage and certain 
short-lived lymphocytes appear to play important roles in the induction phase of the 
immune response  (34--36), long-lived  mononudear  cells  are believed to be mainly 
concerned  with antibody synthesis and the conservation of immunological  memory 
(30, 31). Miller and Cole have, in fact, demonstrated that long-lived small lymphocytes 
and plasma cells are resistant to prolonged treatment with 6-MP and other immuno- 
suppressive agents (24, 25).  Thus, with regard to antibody formation, the action of 
6-MP  appears to be manifested most effectively  in relation to a  phase of cellular 
proliferation which is prominent at the time of induction.  In the use of azathioprine 
or 6-MP for the suppression of homograft rejection,  the immune response to the homo- 
graft may well he suppressed  when treatment with these drugs is begun at the time 
of transplantation, hut following one or more episodes of rejection,  when immunity 
has presumably become established,  it is likely that the anti-inflammatory effect of 
6-MP assumes an important role in maintaining the graft. 
SUMMARY 
The mechanism of action of 6-mercaptopurine (6-MP)  on an egg albumin- 
induced  inflammatory lesion in the  skin has been studied  in rabbits  treated 
with 6-MP in a daily dosage of 18 mg/kg. Relative to control animals, signifi- 
cant  decreases  in  the  numbers  of large  lymphocytes and  monocytes in  the 
blood were observed in the 6-MP-treated animals by the 9th day of treatment, 
without significant decrease in the numbers  of polyrnorphonuclear leukocytes 
and small and medium lymphocytes. Concurrently,  a  significant decrease was 
also seen in the percentage of tissue mononuclear cells in the inflammatory skin 
lesion. There was a highly significant correlation between the numbers of mono- 
cytes in the blood and the per cent of mononuclear cells in the lesion. A mean 
of 52 % of the mononuclear cells in the tissue lesion phagocytosed carbon offer- 
ing further evidence that the major cell involved was the blood monocyte. 
In vitro incorporation of 3H-Tdr by blood mononuclear cells was significantly 
reduced in the 6-MP-treated animals as determined by scintillation counting 
and  radioautography.  The large lymphocyte was  the  predominant  cell type 
which  was  labeled  in  vitro.  Small  lymphocytes and  monocytes were  rarely 
labeled. 
The data obtained  suggest  that  the  anti-inflammatory effect of 6-MP,  re- 
flected in these experiments by a decrease in mononuclear cells in a tissue lesion, 796  ANTI-INFLArd-~rATORY ACTION OF  6-MERCAPTOPURINE 
results  from suppression  of  a  bone  marrow  response  to  local  inflammation, 
affecting  principally  proliferating  precursors  of  blood  monocytes  and  large 
lymphocytes. The possible importance of this action of 6-MP in the treatment 
of inflammatory and  immunologically mediated  disease  is discussed. 
The authors wish to thank Mr. Earl Calahan for his technical assistance. 
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FIG.  1.  Appearance of subcutaneous lesion 4-6 hr after injection of egg white and 
India  ink  in  normal  rabbit.  Both  polymorphonuclear  and  mononuclear leukocytes 
are seen  ×  1000. 
FIG. 2.  Appearance of subcutaneous lesion 4-6 hr after injection of egg white and 
India ink in rabbit following treatment with 6-MP  (18 mg/kg) for 8 days.  Adequate 
numbers  of polymorphonuclear leukocytes  are  seen,  but  no  mononuclear  cells  are 
present  ×  1000. ERIC  R.  ItURD  AND  MORRIS  ZIFF  799 800  ANTI-INFLAMMATORY  ACTION  OF  6-MERCAPTOPURINE 
FIG. 3.  Radioautograph in a control animal showing labeling of a large lymphocyte, 
incubated with 3H-Tdr in vitro for 1 hr. A nonlabeled medium to lane lymphocyte 
and two small lymphocytes are also present ;<  1000. 